Dermatologie Findings Associated with Antiphospholipid Antibody Syndrome

Conley C Hartman R C . A hemorrhagic disorder caused by circulating anticoagulants in patients with disseminated lupus erythematosus. J Clin Invest 1952; 31: 621–22.

Bowie E J Thompson J H Pascuzzi C . Thrombosis in systemic lupus erythematosus despite circulating anticoagulants. J Lab Clin Med 1963; 62: 416–30.

Feinstein D I Rapaport S I . Acquired inhibitors of blood coagulation. Prog Hemost Thromb 1972; 1: 75–96.

Harris E N Gharavi A E Boey M L . Anticardiolipin antibodies: Detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; ii: 1211–14.

Shi W Krilis S A Chong B H . Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population. Aust NZ J Med 1990; 20: 231–36.

Goldberg S N Conti-Kelly A M Greco T P . A family study of anticardiolipin antibodies and associated clinical conditions. Am J Med 1995; 98: 473–79.

Love P E Santoro S A . Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Ann Intern Med 1990; 112: 682–98.

Taylor L M Chitwood R W Dalman R L . Antiphospholipid antibodies in vascular surgery patients. Ann Surg 1994; 220: 544–51.

Alegre V A Gastineau D A Winkelmann R K . Skin lesions associated with circulating lupus anticoagulant. Br J Dermatol 1989; 120: 419–29.

Naldi L Locati F Marchesi L . Cutaneous manifestations associated with antiphospholipid antibodies in patients with suspected primary antiphospholipid syndrome: A case-control study. Ann Rheum Dis 1993; 52: 219–22.

Johansson E A Niemi H M Mustakallio K K . A peripheral vascular syndrome overlapping with systemic lupus erythematosus. Dermatologica 1977; 155: 257–67.

Grob J J Bonerandi J J . Cutaneous manifestations associated with the presence of the lupus anticoagulant. J Am Acad Dermatol 1986; 15: 211–19.

Grattan C E Burton J L Boon A P . Sneddon's syndrome (livedo reticularis and cerebral thrombosis) with livedo vasculitis and anticardiolipin antibodies. Br J Dermatol 1989; 120: 441–47.

Smith K J Skelton H G James W D . Cutaneous histopathologic findings in antiphospholipid syndrome. Correlation with disease, including human immunodeficiency virus disease, Arch Dermatol 1990; 126: 1176–83.

Stephansson E A Niemi K M Jouhikainen T . Lupus anticoagulant and the skin. Acta Derm Venereol (Stockh) 1991; 71: 416–22.

Hughes G R . Connective tissue disease and the skin. Clin Exp Dermatol 1984; 9: 535–44.

Weinstein C Miller M H Axtens R . Livedo reticularis associated with increased titers of anticardiolipin antibodies in systemic lupus erythematosus. Arch Dermatol 1987; 123: 596–600.

Asherson R A Mayou S C Merry P . The spectrum of livedo reticularis and anticardiolipin antibodies. Br J Dermatol 1989; 120: 215–21.

Lockshin M D . Antiphospholipid antibody syndrome. Rheum Dis Clin North Am 1994; 20: 45–56.

Marsch W C H Muckelman R . Generalized racemose livedo with cerebrovascular lesions (Sneddon Syndrome): An occlusive arteriolopathy due to proliferation and migration of medial smooth muscle cells. Br J Dermatol 1985; 112: 703–708.

Khamashta M A Cuadrado M J Mujic F . The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995; 332: 993–97.

Harris E N Gharavi A E Hughes G R V . Antiphospholipid antibodies. Clin Rheum Dis 1985; 11: 591–609.

Sontheimer R D . The anticardiolipin syndrome. A new way to slice an old pie, or a new pie to slice? Arch Dermatol 1987; 123: 590–95.

Dodd H J Sarkany I O'Shaughnessy D . Widespread cutaneous necrosis associated with the lupus anticoagulant. Clin Exp Dermatol 1985; 10: 581–86.

Derksen R H Hasselaar P Blokzijl L . Lack of efficacy of plasma-exchange in removing antiphospholipid antibodies [letter). Lancet 1987; ii: 222.

Vermylen J Blockman D Spitz B . Thrombosis and immune disorders. Clin Haematol 1986; 15: 393–412.